T4 - THYROXINE 12017709122

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a 05,06 report with the FDA on 2014-04-17 for T4 - THYROXINE 12017709122 manufactured by Roche Diagnostics.

Event Text Entries

[4547326] The customer received questionable results for thyroxine (t4) on three patient samples. One of the three samples was run on another instrument, one sample the customer could not clarify which instrument generated the results, and one sample was initially run on this instrument. All results are in ug/dl. Patient 1 was reported outside of the laboratory on (b)(6) 2014 as 20. 1, which was generated on this instrument, a cobas 6000 e601 (e601). The sample was repeated on another e601 and generated a result of 21. 5. The sample was run on a siemens centaur and generated a result of 10. 6. The sample was also run at a reference laboratory and generated a result of 9. 3. The customer was uncertain of the methodology used at the reference laboratory. Patient 2 was reported outside of the laboratory as 21. 7, the date of the report and the instrument it was run on is not known by the customer. The sample was run on a siemens centaur and generated a result of 15. 4. The sample was sent to a different reference laboratory and generated a result of 18. 2. The methodology at the different reference laboratory was unknown to the customer. The customer deemed the results from the other methodologies to be correct for all the samples. There was no adverse event for any of the patients. The serial number of the e601 used in this case was (b)(4). The customer refused a service dispatch for this instrument. The customer does not think there is an instrument issue as the two e601 systems match. For the medwatch for the erroneous results generated on e601 with serial number (b)(4), please see medwatch with patient identifier (b)(4).
Patient Sequence No: 1, Text Type: D, B5


[11765350] It was unknown if the initial reporter sent report to the fda.
Patient Sequence No: 1, Text Type: N, H10


[11817281] On follow up with the customer, they indicated that patient 2 is taking a vitamin d supplement and birth control pills. The patient also had additional thyroid results that were generated on the e411 at the customer's sister laboratory on (b)(6) 2014. The patient had a "t3" result of 184 ng/dl, a "t-uptake" result of 1. 5 tbi, a "tsh" result of 0. 263 uiu/ml and a "t4, free" result of 1. 5 ng/dl.
Patient Sequence No: 1, Text Type: N, H10


[11874768] The investigation could not determine a specific root cause. The samples are not available for investigation. Additional information was requested for investigation, but could not be provided by the customer. Performance data for the reagent was reviewed and within specification. A general reagent issue can be excluded.
Patient Sequence No: 1, Text Type: N, H10


[11903596] On further follow up, the customer indicated that patient 2 returned on (b)(6) 2014 and had another order for t4 testing. The sample was initially run at a sister laboratory on a cobas e411 (e411) instrument and generated a result of 21. 7 ug/dl. The sample was then sent to this laboratory and run on cobas 6000 e601 serial number (b)(4) and generated a result of 20. 0 ug/dl. The sample was then sent to another laboratory and was run on a siemens instrument and the result was 12. 7 ug/dl. The result of 21. 7 ug/dl was reported to the physician, but the physician was informed there was an investigation into a potential interference. The customer deems the other methodology to be correct. There has been no adverse impact to the patient. The sample from (b)(6) 2014, has been requested for further investigation. Please see the medwatch 1823260-2014-03479 for the med watch report submitted for the erroneous results generated on the e411.
Patient Sequence No: 1, Text Type: N, H10


[11970832] The investigation determined that no interfering factors seemed to be present in the investigated sample. It was also determined that no interference from pharmaceuticals seemed to be present either. A general reagent issue was excluded. The difference between the elecsys and other assays could possibly be attributed to differences in methods and instruments, differences in standardization and applications and different antibodies.
Patient Sequence No: 1, Text Type: N, H10


[12059340] Additional testing was performed during the investigation on the sample for patient 2: anti-tg: 58. 02 iu/ml anti-tpo: 86. 69 iu/ml.
Patient Sequence No: 1, Text Type: N, H10


MAUDE Entry Details

Report Number1823260-2014-02770
MDR Report Key3756085
Report Source05,06
Date Received2014-04-17
Date of Report2014-07-28
Date of Event2014-03-28
Date Mfgr Received2014-04-01
Date Added to Maude2014-04-17
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA0
Event Location3
Manufacturer ContactNA MICHAEL LESLIE
Manufacturer Street9115 HAGUE ROAD NA
Manufacturer CityINDIANAPOLIS IN 46250
Manufacturer CountryUS
Manufacturer Postal46250
Manufacturer Phone3175214343
Manufacturer G1ROCHE DIAGNOSTICS GMBH
Manufacturer StreetSANDHOFERSTRASSE 116 NA
Manufacturer CityMANNHEIM (BADEN-WURTTEMBERG) 68305
Manufacturer CountryGM
Manufacturer Postal Code68305
Single Use3
Previous Use Code3
Removal Correction NumberNA
Event Type3
Type of Report3

Device Details

Brand NameT4 - THYROXINE
Generic NameRADIOIMMUNOASSAY, TOTAL THYROXINE
Product CodeCDX
Date Received2014-04-17
Model NumberNA
Catalog Number12017709122
Lot Number17416501
ID NumberNA
Device Expiration Date2015-01-31
OperatorHEALTH PROFESSIONAL
Device AvailabilityY
Device AgeDA
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerROCHE DIAGNOSTICS
Manufacturer Address9115 HAGUE ROAD NA INDIANAPOLIS IN 46250 US 46250


Patients

Patient NumberTreatmentOutcomeDate
10 2014-04-17

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.